Interní Med. 2007; 9(4): 163-166

The treatment of lipid disorders in diabetic patients

doc. MUDr. Vladimír Soška CSc1,2
1 Oddělení klinické a radiační onkologie, FN u svaté Anny v Brně
2 Centrum pro diagnostiku a léčbu dyslipidemií, FN u sv. Anny v Brně

The prevalence of lipid disorders in diabetic patients is very high. It is necessary to differentiate between secondary dyslipidemia caused by insufficient diabetes compensation and dyslipidemia as a separate disorder associated with diabetes mellitus. The combined hyperlipidemia is a typical finding, frequently associated with a decrease of HDL-cholesterol. Frequently we encounter also an increase of apolipoprotein B100 and increased concentration of small LDL3. Target blood levels of lipids are the same as in patients in secondary prevention of cardiovascular diseases. A good control of diabetes, optimizing of body weight, dietary changes and regular physical activity are essential in the treatment. If these measures do not lead to improvement in lipid profile, therapy with hypolipidemics is indicated. The choice of medications should reflect the type of dyslipidemia. Reaching of target levels of LDL-cholesterol or non HDL-cholesterol are the principal goal of treatment. A combined therapy with a statin and a fibrate is indicated in a large number of patients.

Keywords: dyslipidemia, diabetes mellitus, non HDL-cholesterol, apolipoprotein B, triacylglycerols, LDL-cholesterol

Published: June 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Soška V. The treatment of lipid disorders in diabetic patients. Interní Med. 2007;9(4):163-166.
Download citation

References

  1. Cífková R, Býma S, Češka R, et al. Prevence kardiovaskulárních onemocnění v dospělém věku. Společné doporučení českých odborných společností. Vnitřní lékařství, 2005; 51 (9): 1021-1036.
  2. Griffin, et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis, 1994; 106: 241-253. Go to original source... Go to PubMed...
  3. Nauck M, Warnick GR, Rifai N. Methods for measurement of LDL-cholesterol: A critical assessment of direct measurement by homogenous assays versus calculation. Clin Chem, 2002; 48: 236-254. Go to original source...
  4. Sacks FM for the Expert Group on HDL cholesterol: The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: Expert group recommendations. Am. J. Cardiol., 2000; 90: 139-142.
  5. Soška V. Triacylglyceroly jako rizikový faktor pro předčasnou ischemickou chorobu srdeční. Vnitřní lékařství, 46, 2000; 8: 476-479.
  6. Soška V. Poruchy metabolizmu lipidů: Diagnostika a léčba. Grada, Praha 2001: 180 s.
  7. Soška V. Dyslipidémie u metabolického syndromu. Vnitřní lékařství 2005; 51 (1): 77-81.
  8. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). NIH Publication 02-5215. Circulation, 2002; 106: 3143-3420. Go to original source...
  9. Vaverková H, Soška V, Rosolová H, et al. Doporučení pro diagnostiku a léčbu dyslipidémií v dospělosti, vypracované výborem české společnosti pro aterosklerózu. Vnitřní lékařství 2007 (v tisku).




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.